Why the Administration Should Be Flexible with Medtech Tariffs to Protect Patients and Innovation
Flexibility on tariffs is critical to maintaining medtech as the backbone of the U.S. health care system and an American economic success story.
Government & Legislative Affairs
Learn more about our Advocacy work.
Tariffs: Understanding the Nairobi Protocol and related Customs Procedures
Learn how the Nairobi Protocol may support duty-free access for medical devices under new tariffs.
AdvaMed® Releases “AI Policy Roadmap” to Guide Congress and Federal Agencies
Washington, D.C.—AdvaMed, the MedTech Association®, today released its “AI Policy Roadmap,” a detailed policy outline for Congress and the federal agencies with jurisdiction over medtech to consider in promoting the…
Scott Whitaker Op-Ed: Tariffs Should Spare Vital U.S. MedTech Industry
A powerful op-ed from AdvaMed’s CEO explaining why tariffs could undermine U.S. medtech innovation, jobs, and patient care—and what must be done.
AdvaMed® Advancements: Q1 2025 Report
AdvaMed’s Q1 2025 report focuses on tariffs, policy action, and how we’re protecting Medtech innovation.
Bipartisan Health Tech Investment Act Will Enhance Patient Access to AI-Enabled Medical Devices
WASHINGTON – AdvaMed, the MedTech Association®, today commended Senators Mike Rounds (R-SD) and Martin Heinrich (D-NM) for introducing the Health Tech Investment Act (S. 1399). This landmark bipartisan legislation will…
AdvaMed® Statement on President’s Reciprocal Tariff Pause
WASHINGTON – Today AdvaMed, the MedTech Association®, released the following statement from President and CEO Scott Whitaker:
AdvaMed®, Nine Other Organizations Urge Tariff Exemption for Medical Products
Washington, D.C.– AdvaMed, The Medtech Association®, and nine additional organizations urged an exemption from tariffs for medical and dental supplies, equipment, and devices, citing concerns about increased costs resulting in supply…
AdvaMed® Congratulates Dr. Oz on his Confirmation as CMS Administrator
Washington, D.C.– AdvaMed, The Medtech Association®, today released the following statement from President and CEO Scott Whitaker on the U.S. Senate’s confirmation of Dr. Mehmet Oz to serve as Administrator of…
AdvaMed® Statement on Today’s Tariff Announcement
Washington, D.C.– AdvaMed, the MedTech Association®, released the following statement from President and CEO Scott Whitaker: “Our country is the birthplace of the medical device and technology industry and leads the…